CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine

    From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell…
    April 10, 2023| Arthur N. Brodsky, PhD
  • CRI Scientist’s “Rosetta Stone” Tech Unlocks New Era

    Dr. Alex Marson, a CRI-funded STAR, has developed a new genetic screening technology with potential to significantly…

    February 10, 2022| Jill O'Donnell-Tormey, PhD
  • CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher

    Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…

    April 9, 2021| Arthur N. Brodsky, PhD
  • Immunotherapy 101 with Dr. E. John Wherry at the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. E. John Wherry discusses the basics of the immune system and immunotherapy at the 2020 CRI…

    October 27, 2020| Caroline Offit
  • Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen

    CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…

    May 28, 2020| Arthur N. Brodsky, PhD
  • The Role of Viperin in Viral Protection with Dr. Chun-Chieh ‘Jack’ Hsu

    CRI Fellow Dr. Chun-Chieh ‘Jack’ Hsu is exploring how the protein viperin helps protect us against viral…

    May 20, 2020| Arthur N. Brodsky, PhD
  • COVID-19 and the Immune System: How Cancer Research Can Help Rein in the Novel Coronavirus Pandemic

    Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.

    March 25, 2020| Arthur N. Brodsky, PhD
  • A Special Message from the Cancer Research Institute

    CRI has taken steps to ensure the health and safety of our staff and community, and continue…

    March 18, 2020| Jill O'Donnell-Tormey, PhD
  • Meet Dr. Amanda Lund, One of the New CRI Lloyd J. Old STARs

    We spoke with Dr. Amanda Lund to learn more about her work and what she hopes to…

    November 15, 2019| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute